What is the Lymphedema Treatment Act?
What you need to know about the Lymphedema Treatment Act: The Lymphedema Treatment Act is a federal law passed on December 23, 2022, to improve Medicare insurance coverage for the medically necessary, doctor-prescribed compression supplies that are the cornerstone of lymphedema treatment. What you need to know about the Lymphedema Treatment Act?
The Lymphedema Treatment Act (LTA) will provide Medicare coverage for the diagnosis of Lymphedema by amending the Medicare statute to allow for coverage of compression supplies.
The Lymphedema Treatment Act will amend Sec. 1861 [42 U.S.C. 1395x] of the Social Security Act to enable coverage of these items under Durable Medical Equipment.
The main highlights of the passing of this bill will be to:
• Improve insurance coverage for prescribed medical compression supplies.
• Reduce total healthcare costs with lymphedema.
When does the LTA go into effect?
January 1, 2024
As this is a new process, claims filed with the DME MACs (Durable Medical Equipment Medicare Administrative Contractors) will be on a manual review process until all policies are in place which could be well into 2024. We expect updates to occur periodically.
Who is impacted by LTA and how?
The intention of the bill is to provide patients who are diagnosed with lymphedema access to the proper tools to treat this debilitating disease. The LTA will provide benefit coverage for compression therapy products for use in the decongestive and maintenance phases of treatment.